ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Noriyoshi Sawabata
Hajime Maeda
Hikaru Matsuda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawabata, N.
Right arrow Articles by Matsuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawabata, N.
Right arrow Articles by Matsuda, H.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2002;74:1953-1957
© 2002 The Society of Thoracic Surgeons


Original article: general thoracic

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer

Noriyoshi Sawabata, MDa*, Akihide Matsumura, MDb,c, Mitsunori Ohota, MDa, Hajime Maeda, MDa, Hiroshi Hirano, MDb, Katsuhiro Nakagawa, MDd,c, Hikaru Matsuda, MDd Thoracic Surgery Study Group of Osaka University (TSSGO)

a Division of Surgery, Clinical Pathology, Toneyama National Hospital, Osaka, Japan
B Division of Surgery, Kinki Central National Hospital for Chest Diseases Osaka, Japan
C Division of General Thoracic Surgery, Department of Surgery (E-1), Osaka University Graduate School of Medicine Osaka, Japan
D Division of Surgery, Habikino Hospital, Osaka, Japan

Accepted for publication June 28, 2002.

* Address reprint requests to Dr Sawabata, Division of Surgery, Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka 560-8552, Japan.
e-mail: nori{at}toneyama.hosp.go.jp

BACKGROUND: We have developed a novel test for the surgical margin of pulmonary malignant tumor using a cytologic technique (the run-across method in which a glass slide is run across the staple site), and we have assessed whether this method is useful in predicting margin relapse and prognosis.

METHODS: From April 1996 to March 1999, 15 lesions of stage I non-small cell lung cancer (NSCLC) (maximum diameter ranged from 10 to 35 mm with a median of 20 mm) from 15 patients with cardiopulmonary impairment were excised without additional proximal resections. The surgical margin was examined using the run-across method. There were 8 male 7 female patients whose ages ranged from 51 to 80 years. One patient underwent video-assisted thoracic surgery and 14 underwent thoracotomy. The preoperative diagnoses of the patients were 13 adenocarcinomas, 2 squamous cell carcinomas, and 1 undiagnosed lesion (1 adenocarcinoma). The follow-up period ranged from 37 to 63 months.

RESULTS: The rate of positive cytology was 47% in comparison with the rate of positive histology of 20%. There were 4 patients with margin relapse (3 of them contained negative histology margins) at a rate of 57% among the positive cytology patients in comparison with 0% among the negative cytology patients (p = 0.03). In a comparison of survival between the negative cytology group and the positive cytology group, there were no statistically significant differences.

CONCLUSIONS: The run-across method is also useful in confirming complete resection. A positive cytology margin could lead to margin relapse even if a non-small cell lung cancer is resected with a negative histology margin.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Sawabata
A segmentectomy for stage IA non small cell lung cancer should be associated with surgical margin cytology findings and a frozen section histologic examination of lymph nodes
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 822 - 822.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Nomori, K. Ikeda, T. Mori, H. Kobayashi, K. Iwatani, K. Kawanaka, S. Shiraishi, and T. Kobayashi
Reply to the Editor
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 822 - 823.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. El-Sherif, H. C. Fernando, R. Santos, B. Pettiford, J. D. Luketich, J. M. Close, and R. J. Landreneau
Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer
Ann. Surg. Oncol., August 1, 2007; 14(8): 2400 - 2405.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sawabata
Detecting Metastasis of Lung Cancer in Mediastinal Lymph Nodes: The Discrepancy Between Cytology and Histology
Ann. Thorac. Surg., April 1, 2006; 81(4): 1547 - 1547.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. D. T. Daly and T. A. DiPetrillo
Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases?: Reply
Ann. Thorac. Surg., April 1, 2004; 77(4): 1504 - 1504.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sawabata, M. Inoue, S.-i. Takeda, and H. Maeda
Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases?
Ann. Thorac. Surg., April 1, 2004; 77(4): 1503 - 1504.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Sawabata, M. Ohta, A. Matsumura, K. Nakagawa, H. Hirano, H. Maeda, and H. Matsuda
Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study
Ann. Thorac. Surg., February 1, 2004; 77(2): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Higashiyama, K. Kodama, K. Takami, N. Higaki, T. Nakayama, and H. Yokouchi
Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse: Reply to the Editor
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 611 - 611.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Sawabata
Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 610 - 611.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.